Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.10 Analyst target: $12.00 Upside: 990.91%
MAIA Biotechnology Inc. is an innovative biotechnology company focused on developing cutting-edge cancer therapies that significantly improve patient outcomes across various malignancies. Utilizing its proprietary technology platforms, MAIA aims to harness the power of the immune system to create targeted therapies that address critical unmet medical needs in oncology. With a strong development pipeline and a strategic commitment to therapeutic innovation, MAIA is well-positioned to become a prominent participant in the biopharmaceutical sector, capitalizing on emerging growth opportunities within the evolving healthcare landscape.
See the full interactive analysis & chart →Informational only — not investment advice.